/Companies

Ejenta

Techstars '19

San Francisco, US · 5 employees on LinkedIn · 6 known investors

Find your way into Ejenta

Ejenta builds an agentic AI platform for connected care that delivers intelligent healthcare solutions to patient homes and manages care for members with chronic conditions like heart failure. The company partners with health plans and healthcare organizations to enable remote monitoring and intelligent care delivery.

Also known as Ejenta, Inc.

Founders & leadership

RDRachna Dhamija
Rachna DhamijaCEO

Investors · 6

Company profile

researched Sep 2026

Ejenta is a San Francisco-based health technology company that develops an agentic AI platform for connected care. Its intelligent agents ingest data from sensors and IoT devices to learn individual patient patterns, detect abnormalities and predict health deterioration in advance, and then act autonomously to communicate with users, surface actionable data and keep care teams connected. The stated goal of the platform is to automate remote monitoring and remote care delivery in the patient's home.

The company works with payers and health systems as well as in space health research. It has run work with Point32Health, the parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, including a remote monitoring pilot and later reported results among members with heart failure. In parallel, Ejenta collaborates with the AI team in NASA's Human Research Program, with support from the Translational Research Institute for Space Health (TRISH), on AI tools for clinical decision support, and was selected by TRISH for spaceflight healthcare and data management work alongside consortium partners MIT and Caltech.

Traction

Ejenta has a remote monitoring pilot and subsequent heart failure outcomes work with Point32Health, selection by TRISH (Baylor College of Medicine, with MIT and Caltech) for two spaceflight healthcare and data management projects, an ongoing collaboration with NASA's Human Research Program AI team on clinical decision support, and a Best in Show award at HIMSS26. It was also selected for the MassChallenge HealthTech 2021 cohort and lists open roles on AngelList.

Latest developments

In March 2026 Ejenta announced it won Best in Show at HIMSS26 for Total Cost of Care Reduction for Payers and planned a presentation by CEO Rachna Dhamija at the Emerge Showcase on March 11, 2026. In October 2025 it announced a collaboration with the AI team in NASA's Human Research Program, supported by TRISH, to test AI tools for clinical decision support. In May 2025 the CEO presented results from Point32Health members with heart failure at the Mass General Brigham MESH Core 2025 Conference, and in March 2025 presented at HIMSS25 at the AWS booth.

▸Full profile — market position, technology, go-to-market, geography

Market position

Positioned as a provider of AI-driven remote monitoring and connected care for payers, emphasizing reduction of total cost of care; recognized with Best in Show at HIMSS26 for Total Cost of Care Reduction for Payers and selected into the MassChallenge HealthTech 2021 digital health cohort.

Technology

The platform is built on AI technology licensed to NASA, where intelligent agents run continuously in NASA's Mission Control for the International Space Station. Ejenta's agents draw on sensor and IoT device data for personalized learning about each user, anomaly detection and advance prediction of health deterioration, and operate autonomously to interact with users, encourage healthy behavior and relay actionable information to care teams. The company has presented its work in partnership with Amazon Web Services.

Go-to-market

Ejenta reaches customers through partnerships and pilots with payers and health systems (for example Point32Health and Mass General Brigham conference engagement), presence and speaking slots at industry events such as HIMSS, co-marketing with cloud partner AWS, participation in accelerator programs including the MassChallenge HealthTech 2021 cohort, and government/research programs with NASA and TRISH.

Health plans and payers, healthcare provider organizations, and their members or patients managing chronic conditions such as heart failure; also space health research programs supporting crew health during spaceflight.

Geography

Headquartered at 181 2nd Street, San Francisco, California, with program and conference activity in the United States including Massachusetts (Point32Health, Mass General Brigham MESH Core conference) and Nevada (HIMSS).

Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
HeadcountAug 20265

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 5

by search overlap
Tsenta17 shared keywordsTsenta automates job applications by monitoring 50,000+ career pages across major applicant tracking systems and submitting tailored, ATS-optimized applications within minutes of job postings. The platform serves active job seekers seeking to increase application volume and speed while maintaining quality application materials.
Genenta16 shared keywordsGenenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.
Agenta11 shared keywordsAgenta is an open-source platform for AI teams to experiment with prompts and models, evaluate their performance, and collaborate on debugging and optimization. It provides version control, tracing, automated evaluation, and monitoring tools for large language model applications.
Enanta Pharmaceuticals11 shared keywordsEnanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).
Kayenta9 shared keywordsKayenta provides a cloud-native treasury management system for investment managers, offering a low-cost core product with optional add-on modules. The platform delivers analytics and data-backed insights to support treasury decisions for the investment management industry.

Companies competing with Ejenta for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of DefenseDefense Health ProgramPhase I2017$149.9K
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase II2015$750.3K
Department of Homeland SecurityPhase I2014$100K
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase II2013$1M
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase I2012$148.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Timeline · 7

launches, deals, and filings
Mar 2026
Ejenta wins Best in Show at HIMSS26

Ejenta announced it won Best in Show at HIMSS26 for Total Cost of Care Reduction for Payers; CEO Rachna Dhamija scheduled to present at the Emerge Showcase on March 11, 2026.

source ↗

Oct 2025
Collaboration with NASA Human Research Program AI Team, supported by TRISH

Ejenta is collaborating with the AI Team in NASA's Human Research Program, with support from the Translational Research Institute for Space Health, to test AI tools for clinical decision support for crew health during Earth-independent medical operations.

source ↗

May 2025
CEO presents Point32Health heart failure results at MGB MESH Core 2025

CEO Rachna Dhamija presented "Agentic AI Platform for Connected Care: Results from Point32Health Members with Heart Failure" at the Mass General Brigham MESH Core 2025 Conference in Somerville, MA (May 12-13, 2025).

source ↗

Mar 2025
Ejenta presents at HIMSS25 in partnership with AWS

CEO Rachna Dhamija presented "Intelligent Agents for Connected Care: From Space to Earth" at the AWS booth during the HIMSS25 Global Health Conference & Exhibition in Las Vegas.

source ↗

Nov 2023
TRISH selects Ejenta for spaceflight healthcare and data management

The Translational Research Institute for Space Health at Baylor College of Medicine, with consortium partners MIT and Caltech, announced two new projects to improve healthcare delivery and data management for spaceflight participants and researchers, selecting Ejenta.

source ↗

Jun 2022
Point32Health to pilot Ejenta remote monitoring

Point32Health, parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, teamed up with Ejenta to pilot automated remote monitoring and remote care delivery.

source ↗

Dec 2020
Selected for MassChallenge HealthTech 2021 cohort

Ejenta was named among the 30 digital health startups in the MassChallenge HealthTech 2021 cohort, described as an intelligent agent using NASA-licensed AI technology to provide personalized remote care.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

▸Research sources · 6

primary sources listed

6 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Ejenta do?
Ejenta runs an agentic AI platform for connected care, using NASA-licensed intelligent agents for remote patient monitoring.
Who founded Ejenta?
Ejenta was founded by Rachna Dhamija.
Who are Ejenta's investors?
Ejenta's investors include 15th Rock, aVenture, City Light, Techstars, Yamaha Motor Ventures, Founders' Co-op.
Where is Ejenta headquartered?
Ejenta is headquartered in San Francisco, US.